X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

GANX

Closed

Gain Therapeutics Inc

1.57
-0.23 (-12.78%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.8
Day's Range: 1.56 - 1.75
Send
When Written:
 
4.89
Gain Therapeutics Inc. is a biotechnology company that specializes in developing small molecule therapeutics for rare genetic diseases. The company's proprietary drug discovery platform, Site-Directed Enzyme Enhancement Therapy (SEE-Tx), identifies and optimizes allosteric binding sites on enzymes, which can be targeted with small molecule drugs. Gain Therapeutics is focused on developing treatments for lysosomal storage disorders, which are a group of rare genetic diseases caused by the accumulation of toxic substances in cells due to deficiencies in lysosomal enzymes. The company's lead program is focused on developing a treatment for Gaucher disease, a lysosomal storage disorder that affects approximately 10,000 people worldwide. Gain Therapeutics was founded in 2017 and is headquartered in Lugano, Switzerland, with additional offices in Bethesda, Maryland, and Barcelona, Spain.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X